Brean Capital Boosts Onyx Pharma (ONXX) Price Target to $160
Go back to Brean Capital Boosts Onyx Pharma (ONXX) Price Target to $160| Amgen Inc (NASDAQ: AMGN) | Delayed: 438.60 -1.74 (0.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $440.34 | 52 Week High | $176.85 | |||
| Open | $433.08 | 52 Week Low | $133.64 | |||
| Day High | $442.13 | P/E | 66.05 | |||
| Day Low | $431.01 | EPS | $6.64 | |||
| Volume | 875,280 | |||||
| Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) | Delayed: 124.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.70 | 52 Week High | $136.87 | |||
| Open | $124.70 | 52 Week Low | $68.12 | |||
| Day High | $124.70 | P/E | N/A | |||
| Day Low | $124.70 | EPS | $-1.58 | |||
| Volume | 514,854 | |||||
